CSL (CSLLY) Accounts Payable & Accrued Expense : $2,897 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is CSL Accounts Payable & Accrued Expense?

CSL's quarterly accounts payable & accrued expense increased from Dec. 2022 ($2,559 Mil) to Jun. 2023 ($2,947 Mil) but then declined from Jun. 2023 ($2,947 Mil) to Dec. 2023 ($2,897 Mil).

CSL's annual accounts payable & accrued expense increased from Jun. 2021 ($2,040 Mil) to Jun. 2022 ($2,301 Mil) and increased from Jun. 2022 ($2,301 Mil) to Jun. 2023 ($2,947 Mil).

CSL Accounts Payable & Accrued Expense Historical Data

The historical data trend for CSL's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Accounts Payable & Accrued Expense Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,407.70

1,525.40

2,039.70

2,301.20

2,947.00

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,726.50	2,301.20	2,559.00	2,947.00	2,897.00

CSL Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CSL (CSLLY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CSLLY) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CMXHF:USA CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.